Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Archimed sells Diesse stake to Fremman

ARCHIMED, a global investment firm focused on sustainable healthcare, has announced the sale of DIESSE, an Italian producer of specialty in-vitro diagnostics (IVD) solutions, to private equity firm Fremman Capital. 

PureHealth’s HHG acquisition signals Middle East’s growing footprint in European healthcare

PureHealth, the Middle East’s largest hospital group by revenue, is acquiring a 60% stake in Greece’s private healthcare giant, Hellenic Healthcare Group (HHG), in a deal valuing HHG at $2.31 billion. Jersey-based private equity firm CVC Capital Partners, which currently owns 90% of HHG, will retain a 35% stake, while HHG’s CEO, Dimitris Spyridis, will keep 5%. The deal is subject to regulatory approvals, after which CVC and HHG management will hold a combined 40% stake and remain strategic partners in the company’s growth.  PureHealth has not disclosed the timeline for completion.

How the Medical Credit Fund and PharmAccess are enhancing healthcare access and infrastructure in Sub-Saharan Africa — and what Europe can learn from Africa

Healthcare systems around the world are increasingly overstretched, fragmented, and facing growing disease burdens and rising costs. While established markets such as Europe grapple with demographic shifts and rising demand within mature but strained systems, Sub-Saharan Africa (SSA) is confronting the urgent need to build infrastructure and scale healthcare provision to serve a growing population. […]

Find Us